Recombinant Human LAG-3/CD233 (C-Fc) #abs04663

Recombinant Human LAG-3/CD233 (C-Fc) #abs04663

Dear valued customer, Please be informed that the price mentioned earlier is only for your reference. If you require detailed pricing information, please do not hesitate to contact our skilled seller, Vecent. They will be more than happy to assist you in any way possible. Kindly note that our...

Description

Catalog-specification

Delivery time

USD price

abs04663-10ug

1-2 Weeks

138

abs04663-50ug

1-2 Weeks

382

abs04663-500ug

1-2 Weeks

1711

abs04663-1mg

1-2 Weeks

2328

Dear valued customer,
Please be informed that the price mentioned earlier is only for your reference. If you require detailed pricing information, please do not hesitate to contact our skilled seller, Vecent. They will be more than happy to assist you in any way possible.
Kindly note that our team is committed to providing you with the best possible service and support during your entire purchasing process. We look forward to hearing from you soon and providing you with the most accurate and updated pricing details.
Thank you for choosing our company.
Best regards,
[Your Company Name]


Overview

Description

Our Mammalian expression system produces Recombinant Human Lymphocyte Activation Gene 3 Protein, which has the Leu23-Leu450 target gene expressed with a Fc tag at the C-terminus. To create similar content, the information can be rearranged to state that the protein is expressed with a Fc tag at the C-terminus via the Leu23-Leu450 target gene through our Mammalian expression system. The resulting protein, Recombinant Human Lymphocyte Activation Gene 3 Protein, is therefore highly pure and similar to the original protein from which it was derived.

Other names

Protein FDC; CD223

Source

Human Cells

Format

The content was obtained by filtering a solution of PBS with a pore size of 0.2 μm and subsequently lyophilized. The pH of the solution was maintained at 7.4 throughout the process.

Properties

aa_sequence

Rearranged:
The sequence LQPGAEVPVVWAQEGAPAQLPCSPTIPLQDLSLLRRAGVTWQHQPDSGPPAAAPGHPLAPGPHPA APSSWGPRPRRYTVLSVGPGGLRSGRLPLQPRVQLDERGRQRGDFSLWLRPARRADAGEYRAAVH LRDRALSCRLRLRLGQASMTASPPGSLRASDWVILNCSFSRPDRPASVHWFRNRGQGRVPVRESP HHHLAESFLFLPQVSPMDSGPWGCILTYRDGFNVSIMYNLTVLGLEPPTPLTVYAGAGSRVGLPC RLPAGVGTRSFLTAKWTPPGGGPDLLVTGDNGDFTLRLEDVSQAQAGTYTCHIHLQEQQLNATVT LAIITVTPKSFGSPGSLGKLLCEVTPVSGQERFVWSSLDTPSQRSFSGPWLEAQEAQLLSQPWQC QLYQGERLLGAAVYFTELSSPGAQRSGRAPGALPAGHLVDDIEGRMDEPKSCDKTHTCPPCPAPE LLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNS TYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQV SLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVM HEALHNHYTQKSLSLSPGK can generate a lot of interesting and helpful insights.
Based on the original text, there are a lot of potential insights that can be obtained by rearranging the sequence of the text. For example, by identifying key patterns within the text, it may be possible to identify key patterns within the underlying processes that led to the creation of the text in the first place. By analyzing these patterns, it may be possible to identify potential insights that could be useful in a wide range of different contexts, from marketing and branding to scientific research and beyond. Additionally, by carefully considering patterns within the text, it may be possible to generate new insights that have not been previously considered or explored. Ultimately, the key to obtaining valuable insights from the original text lies in carefully analyzing and rearranging its underlying structure to reveal its true meaning and potential.

Concentration

The protein purity was assessed through SDS-PAGE and the result showed that it is greater than 95% pure. This indicates that the sample went through a successful purification process, resulting in a highly homogeneous protein sample.

Endotoxin_level

According to the LAL test, the presence of the substance is confirmed to be below 0.1 ng/μg (1 IEU/μg). I can provide similar content by rephrasing the original text while maintaining its information.

Reconstitution

Before opening, always centrifuge tubes. Do not mix by pipetting or vortexing. It is not advisable to reconstitute to a concentration below 100 μg/ml. Dissolve the lyophilized protein in ddH2O. To minimize freeze-thaw cycles, please divide the reconstituted solution into aliquots. Please ensure the generated content is different from the original text and does not follow the conversation format used by ChapGPT.

Target

Background

Human Lymphocyte activation gene 3 protein (LAG3) is a member of immunoglobulin (Ig) superfamily. LAG3 contains 4 extracellular Ig-like domains. The LAG3 gene contains 8 exons. LAG3 is involved in lymphocyte activation and can bind to HLA class-II antigens. It is selectively expressed in activated T and NK cells. LAG3 has a negative regulatory function in T cells and acts as as a new marker of T cell induced B cell activation. As a soluble molecule, LAG3 activates antigen-presenting cells through MHC class II signaling. It can lead to increased antigen-specific T-cell responses in vivo. LAG-3 has higher affinity to MHC class II than CD4.

Accession

P18627


This product is for research use only, not for use in diagnostic prodecures or in human.


Hot Tags: recombinant human lag-3/cd233 (c-fc) #abs04663, China recombinant human lag-3/cd233 (c-fc) #abs04663 suppliers

You Might Also Like

Shopping Bags